highperformr logo

Cepi's Overview

Total employees136
HeadquartersOslo
Founded1992

The Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative global partnership launched in 2017, involving public, private, philanthropic, and civil society organizations. CEPI's mission is to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks. It funds promising vaccine candidates, supports clinical trials, and invests in new vaccine technologies and manufacturing capabilities. CEPI aims to make pandemics preventable by focusing on WHO-prioritized pathogens like Lassa fever, MERS, Nipah, and preparing for 'Disease X'.

Where is Cepi's Headquarters?

HQ Function

The Oslo headquarters serves as the central nerve center for CEPI's global operations, driving strategic planning, scientific oversight, financial management, resource mobilization, and the coordination of its worldwide vaccine development programs and partnerships.

Notable Features:

CEPI's Oslo office is situated in a modern office building designed to facilitate collaboration and efficient operations. The focus is on a functional and accessible workspace rather than specific architectural grandeur.

Work Culture:

The work culture at CEPI HQ is dynamic, intensely mission-driven, and highly collaborative, reflecting its global team of experts. It's characterized by scientific rigor, a sense of urgency in addressing public health challenges, and a commitment to innovation and partnership.

HQ Significance:

Oslo provides a neutral and stable environment conducive to CEPI's global partnership model. Norway is a founding investor and a strong proponent of global health, making Oslo an ideal base for an organization of CEPI's nature.

Values Reflected in HQ: The headquarters' operations and collaborative environment reflect CEPI's core values of scientific excellence, transparency, equity, and partnership in its pursuit of global health security.

Location:

CEPI's global presence is defined by its extensive network of partnerships and funded projects spanning multiple continents. It supports vaccine development with research institutions, biotech companies, and manufacturers worldwide. Key functions supported globally include strategic investments in vaccine R&D, oversight of international clinical trials, fostering innovation in vaccine platforms (like mRNA technology), building manufacturing capabilities, and championing equitable access to vaccines, particularly for low- and middle-income countries. This is achieved through its diverse international team and collaborations in regions critical for epidemic preparedness.

Street Address:

Marcus Thranes gate 2

City:

Oslo

State/Province:

Oslo

Country:

Norway

Cepi's Global Presence

London, United Kingdom

Address: The Epworth, 25 City Road, London, EC1Y 1AA, UK

Facilitates critical collaborations in Europe, a key hub for scientific innovation, pharmaceutical development, and global health funding and policy.

Washington D.C., USA

Address: 1200 18th Street NW, Suite 700, Washington, DC 20036, USA

Essential for engaging with major global health funders, regulatory bodies, policymakers, and the significant biotech and pharmaceutical sectors in North America.

Buying Intent Signals for Cepi

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cepi

As of April 2025, Cepi' leadership includes:

Richard Hatchett - Chief Executive Officer
Frederik Kristensen - Deputy CEO and Head of CEPI Oslo Office
Melanie Saville - Executive Director, Vaccine R&D
Mario Christodoulou - Executive Director, Finance and Corporate Operations
Michelle Gayer - Executive Director, Portfolio Management
Nicole Lurie - Executive Director, CEPI US
Aurélia Nguyen - Chief Programme Officer
Charley Daniel John - Executive Director, Manufacturing, Supply Chain and Access

Investors of Cepi

Cepi has been backed by several prominent investors over the years, including:

Government of Norway
Bill & Melinda Gates Foundation
Wellcome Trust
Government of Germany
Government of Japan
Government of the United Kingdom
European Commission
Government of Canada
Government of Australia
Government of Belgium
Government of Denmark
Government of Ethiopia
Other public and philanthropic partners

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

CEPI's core executive leadership team has demonstrated stability over the past 12 months (June 2023 - June 2024). One notable internal role evolution involved Aurélia Nguyen taking on the position of Chief Programme Officer. No major new external hires into, or departures from, the top-tier executive team have been widely publicized during this period.

New Appointments:

Aurélia Nguyen, Aurélia Nguyen transitioned to the role of Chief Programme Officer, enhancing strategic oversight and coordination of CEPI's diverse vaccine development programmes.

Technology (Tech Stack) used by Cepi

Discover the tools Cepi uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cepi Email Formats and Examples

CEPI's professional email addresses are expected to follow a common corporate structure, typically combining names with the '@cepi.net' domain. The most probable format is [first].[last]@cepi.net.

[first].[last]@cepi.net

Format

richard.hatchett@cepi.net

Example

85%

Success rate

News and media

CEPI NewsJune 18, 2024

CEPI to provide up to US$19.3 million to support development and manufacturing of an mRNA vaccine candidate against Rift Valley fever

CEPI announced a partnership with the University of Cambridge and DIOSynVax, providing up to US$19.3 million to advance an mRNA vaccine candidate against Rift Valley fever through preclinical studies, Phase I/II trials, and manufacturing process establishment....more

CEPI NewsMay 21, 2024

CEPI and ICMR partner to advance development of vaccines against Nipah virus

CEPI and the Indian Council of Medical Research (ICMR) have formed a partnership to advance the development of Nipah virus vaccines in India, leveraging local research and manufacturing capabilities to combat this deadly pathogen....more

CEPI NewsApril 25, 2024

CEPI launches call for proposals to advance vaccine candidates for Henipavirus using novel rapid response platforms

CEPI issued a Call for Proposals seeking to fund the development of vaccine candidates against Henipaviruses (Nipah and Hendra viruses) utilizing innovative rapid response vaccine platforms to enhance global preparedness....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cepi, are just a search away.